The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Multiple states have reached a tentative new agreement with the Sackler family, who made billions of dollars marketing OxyContin, the drug that set off the U.S. opioid crisis. New York State Attorney ...

Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits filed by state and local governments across the country is ...

Mr. Agather writes Jan. 23, “I hate to see stupidity rewarded.” As for me, I hate to see false and misleading claims rewarded. Hurricane-force winds and extraordinarily dry conditions were the prime ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

Suzetrigine is an orally available pain signal inhibitor that selectively targets the NaV1.8 voltage-gated sodium channel, a genetically validated pain target found on peripheral neurons. NaV1.8 is ...

Family members can receive up to $5,000 to cover services including childcare costs, clinical therapy or behavioral health ...

When the White House budget office released a memo this week that instructed all federal agencies to cease spending on any ...

Launched in 2014 by then— Purdue President Mitch Daniels and continued in 2023 by President Mung Chiang, the Presidential Lecture Series exposes Purdue students and the broader community to inspiring ...

Rights Aug 02, 2023 Aug 02, 2023 Feb 08, 2023 Rights ratio: 5 share for every 46 held at a price of Rs 81.0 ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,02,211.39 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...